AIMC Topic: Clinical Trials, Phase II as Topic

Clear Filters Showing 11 to 12 of 12 articles

Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH.

Journal of hepatology May 1, 2025
BACKGROUND & AIMS: Intra and inter-pathologist variability poses a significant challenge in metabolic dysfunction-associated steatohepatitis (MASH) biopsy evaluation, leading to suboptimal selection of patients and confounded assessment of histologic...
Humans Artificial Intelligence Reproducibility of Results Severity of Illness Index Fatty Liver Liver Cirrhosis Liver Multicenter Studies as Topic Randomized Controlled Trials as Topic Clinical Trials, Phase II as Topic Biopsy Pathologists Cross-Over Studies Observer Variation
View on PubMed DOI

Explainable machine learning prediction of edema adverse events in patients treated with tepotinib.

Clinical and translational science Sep 1, 2024
Tepotinib is approved for the treatment of patients with non-small-cell lung cancer harboring MET exon 14 skipping alterations. While edema is the most prevalent adverse event (AE) and a known class effect of MET inhibitors including tepotinib, there...
Humans Machine Learning Female Aged Adult Male Middle Aged Antineoplastic Agents Lung Neoplasms Carcinoma, Non-Small-Cell Lung Clinical Trials, Phase II as Topic Piperidines Protein Kinase Inhibitors Pyrimidines Clinical Trials, Phase I as Topic Edema Pyridazines
View on PubMed DOI
Popular Topics
Recent Journals